Frequency of severe infections and correlation with immune markers in patients with neuromyelitis optica spectrum disorders treated with rituximab: a Swedish cohort study

被引：0
|
作者：
Carlsson, Olof [1 ,2 ]
Jonsson, Dagur Ingi [1 ,3 ]
Brundin, Lou [1 ,2 ]
Iacobaeus, Ellen [1 ,2 ]
机构：
[1] Karolinska Inst, Dept Clin Neurosci, Stockholm, Sweden
[2] Karolinska Univ Hosp, Dept Neurol, Stockholm, Sweden
[3] Karolinska Univ Hosp, Dept Neurophysiol, Stockholm, Sweden
来源：
MULTIPLE SCLEROSIS JOURNAL | 2023年 / 29卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P722/1414
引用
收藏
页码：622 / 623
页数：2
相关论文
共 50 条
  • [31] Relationship between the Clinical Characteristics in Patients with Neuromyelitis Optica Spectrum Disorders and Clinical Immune Indicators: A Retrospective Study
    Cai, Linjun
    Shi, Ziyan
    Chen, Hongxi
    Du, Qin
    Zhang, Ying
    Zhao, Zhengyang
    Wang, Jiancheng
    Lang, Yanling
    Kong, Lingyao
    Zhou, Hongyu
    [J]. BRAIN SCIENCES, 2022, 12 (03)
  • [32] Effectiveness of Lower Rituximab Doses in Neuromyelitis Optica Spectrum Disorder: A Population-based Cohort Study
    Iordanova, Radostina
    Smith, Jessica
    Gonzales, Edlin
    Lee, Angus
    Li, Bonnie
    Langer-Gould, Annette
    [J]. NEUROLOGY, 2023, 100 (17)
  • [33] Therapeutic target of memory B-cells depletion helps to tailor administration frequency of Rituximab in neuromyelitis optica spectrum disorders patients
    Romero, G.
    Bas, J.
    Cohen, M.
    Ticchioni, M.
    Pelletier, J.
    Audoin, B.
    Lebrun-Frenay, C.
    [J]. EUROPEAN JOURNAL OF NEUROLOGY, 2016, 23 : 849 - 849
  • [34] Health-related quality of life in neuromyelitis optica spectrum disorders patients in an Argentinean cohort
    Carnero Contentti, E.
    Eizaguirre, M. B.
    Lopez, P.
    Rojas, J. I.
    Tkachuk, V.
    Alonso, R.
    [J]. MULTIPLE SCLEROSIS JOURNAL, 2021, 27 (2_SUPPL) : 285 - 286
  • [35] Validation of the 2015 diagnostic criteria for neuromyelitis optica spectrum disorders in a cohort of South Indian patients
    Kanikannan, Meena A.
    Arepareddy, Praveen Kumar
    Mathukumalli, Neeharika L.
    Sireesha, Y.
    Kandadai, Rukmini Mridula
    Jabeen, Afshan S.
    Suryaprabha, T.
    Borgohain, Rupam
    [J]. MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2019, 35 : 164 - 169
  • [36] Application of the 2015 diagnostic criteria for neuromyelitis optica spectrum disorders in a cohort of Latin American patients
    Carnero Contentti, E.
    Soto de Castillo, I.
    Daccach Marques, V.
    Lopez, P. A.
    Antunes Barreira, A.
    Armas, E.
    de Aquino Cruz, C.
    Rubstein, A.
    Lavigne Moreira, C.
    Molina, O. M.
    Soto, A.
    Tkachuk, V.
    [J]. MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2018, 20 : 109 - 114
  • [37] Efficacy and safety of modified reduced-dose rituximab in Chinese patients with neuromyelitis optica spectrum disorder: A retrospective cohort study
    Cao, Shugang
    Yu, Hai
    Tian, Jingluan
    Li, Yuanyuan
    Shen, Yueping
    Ji, Xiaopei
    Wang, Xiaoyuan
    Zhou, Xiaoling
    Gu, Yanzheng
    Zhu, Feng
    Duan, Xiaoyu
    Xiao, Xinyi
    Fang, Qi
    Chen, Xiangjun
    Xue, Qun
    [J]. JOURNAL OF THE NEUROLOGICAL SCIENCES, 2021, 429
  • [38] Incidence of neuromyelitis optica spectrum disorders in China: a large cohort study using claim data
    Wu, Yiqun
    Yang, Mo
    Gao, Pei
    Wang, Zijing
    Wu, Junhui
    Wang, Jiating
    Xu, Quangang
    Zhou, Huanfen
    Wu, Tao
    Wu, Weiping
    Wei, Shihui
    Hu, Yong-Hua
    [J]. BMJ OPEN, 2022, 12 (01):
  • [39] Rituximab abrogates aquaporin-4-specific germinal center activity in patients with neuromyelitis optica spectrum disorders
    Damato, Valentina
    Theorell, Jakob
    Al-Diwani, Adam
    Kienzler, Anne-Kathrin
    Makuch, Mateusz
    Sun, Bo
    Handel, Adam
    Akdeniz, Deniz
    Berretta, Antonio
    Ramanathan, Sudarshini
    Fower, Andrew
    Whittam, Daniel
    Gibbons, Emily
    McGlashan, Nicholas
    Green, Edward
    Huda, Saif
    Woodhall, Mark
    Palace, Jacqueline
    Sheerin, Fintan
    Waters, Patrick
    Leite, Maria, I
    Jacob, Anu
    Irani, Sarosh R.
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2022, 119 (24)
  • [40] Efficacy and safety of eculizumab in patients with neuromyelitis optica spectrum disorder previously treated with rituximab: findings from PREVENT
    Levy, M.
    Berthele, A.
    Kim, H. J.
    Fujihara, K.
    Nakashima, I.
    Oreja-Guevara, C.
    Palace, J.
    Pittock, S.
    Terzi, M.
    Totolyan, N.
    Viswanathan, S.
    Wang, K. -C.
    Pace, A.
    Yountz, M.
    Lawson, D.
    Laudon-Meyer, E.
    Wingerchuk, D.
    [J]. MULTIPLE SCLEROSIS JOURNAL, 2020, 26 (3_SUPPL) : 1 - 2
12345